LILLY ENDOWMENT INC, an insider of Eli Lilly and Co (LLY), sold 93,929,782 shares at $917.26 each on November 4, 2025, resulting in a total transaction value of $86,158.41 million. Following this sale, LILLY ENDOWMENT INC retains 93,929,782 shares of the company.
This transaction highlights the significant movement of shares within the company. Eli Lilly, a major player in the pharmaceuticals industry, is headquartered in Indianapolis, Indiana, and employs 47,000 full-time staff. The company is engaged in the discovery, development, manufacture, and sale of pharmaceutical products, with a market capitalization of $886.2 billion and a P/E ratio of 48.13.
Insider transactions are required to be reported to the SEC, providing insight into how company executives and board members perceive their stock. While this sale represents one data point, investors should consider patterns of insider activity across multiple insiders and time periods when evaluating these signals. Upcoming earnings are anticipated on April 28, 2026, with an estimated EPS of $7.07 and revenue of $17.2 billion, further informing market perspectives on the company.